Victory Capital Management Inc Orgenesis Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.6 - $7.84 $8,445 - $18,392	-2,346 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.76 - $5.44 $626 - $1,234	227 Added 10.71%	2,346 $9,000
Q4 2019 Feb 04, 2020	SELL	$2.6 - $4.66 $600 - $1,076	-231 Reduced 9.83%	2,119 $11,000
Q3 2019 Nov 12, 2019	BUY	$4.18 - $4.85 $9,823 - $11,397	2,350 New	2,350 $11,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.